Literature DB >> 27587407

HDL Particle Size and Functional Heterogeneity.

Sergio Fazio1, Nathalie Pamir2.   

Abstract

Entities:  

Keywords:  Editorials; HDL cholesterol; HDL function; HDL particle size; reverse cholesterol transport; sterol efflux

Mesh：

Substances：

Year:  2016        PMID： 27587407      PMCID： PMC5971193          DOI： 10.1161/CIRCRESAHA.116.309506

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  21 in total

1.  Niacin Therapy Increases High-Density Lipoprotein Particles and Total Cholesterol Efflux Capacity But Not ABCA1-Specific Cholesterol Efflux in Statin-Treated Subjects.

Authors:  Graziella E Ronsein; Patrick M Hutchins; Daniel Isquith; Tomas Vaisar; Xue-Qiao Zhao; Jay W Heinecke
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-12-17       Impact factor: 8.311

2.  Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease.

Authors:  Ruth Frikke-Schmidt; Børge G Nordestgaard; Maria C A Stene; Amar A Sethi; Alan T Remaley; Peter Schnohr; Peer Grande; Anne Tybjaerg-Hansen
Journal:  JAMA       Date:  2008-06-04       Impact factor: 56.272

3.  High-Density Lipoprotein Proteomic Composition, and not Efflux Capacity, Reflects Differential Modulation of Reverse Cholesterol Transport by Saturated and Monounsaturated Fat Diets.

Authors:  Marcella O'Reilly; Eugene Dillon; Weili Guo; Orla Finucane; Aoibheann McMorrow; Aoife Murphy; Claire Lyons; Daniel Jones; Miriam Ryan; Michael Gibney; Eileen Gibney; Lorraine Brennan; Margarita de la Llera Moya; Muredach P Reilly; Helen M Roche; Fiona C McGillicuddy
Journal:  Circulation       Date:  2016-04-14       Impact factor: 29.690

Review 4.  High-density lipoprotein--the clinical implications of recent studies.

Authors:  D J Gordon; B M Rifkind
Journal:  N Engl J Med       Date:  1989-11-09       Impact factor: 91.245

5.  High density lipoprotein cholesterol and mortality. The Framingham Heart Study.

Authors:  P W Wilson; R D Abbott; W P Castelli
Journal:  Arteriosclerosis       Date:  1988 Nov-Dec

6.  HDL cholesterol efflux capacity and incident cardiovascular events.

Authors:  Anand Rohatgi; Amit Khera; Jarett D Berry; Edward G Givens; Colby R Ayers; Kyle E Wedin; Ian J Neeland; Ivan S Yuhanna; Daniel R Rader; James A de Lemos; Philip W Shaul
Journal:  N Engl J Med       Date:  2014-11-18       Impact factor: 91.245

7.  Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease.

Authors:  Paolo Zanoni; Sumeet A Khetarpal; Daniel B Larach; William F Hancock-Cerutti; John S Millar; Marina Cuchel; Stephanie DerOhannessian; Anatol Kontush; Praveen Surendran; Danish Saleheen; Stella Trompet; J Wouter Jukema; Anton De Craen; Panos Deloukas; Naveed Sattar; Ian Ford; Chris Packard; Abdullah al Shafi Majumder; Dewan S Alam; Emanuele Di Angelantonio; Goncalo Abecasis; Rajiv Chowdhury; Jeanette Erdmann; Børge G Nordestgaard; Sune F Nielsen; Anne Tybjærg-Hansen; Ruth Frikke Schmidt; Kari Kuulasmaa; Dajiang J Liu; Markus Perola; Stefan Blankenberg; Veikko Salomaa; Satu Männistö; Philippe Amouyel; Dominique Arveiler; Jean Ferrieres; Martina Müller-Nurasyid; Marco Ferrario; Frank Kee; Cristen J Willer; Nilesh Samani; Heribert Schunkert; Adam S Butterworth; Joanna M M Howson; Gina M Peloso; Nathan O Stitziel; John Danesh; Sekar Kathiresan; Daniel J Rader
Journal:  Science       Date:  2016-03-11       Impact factor: 47.728

8.  Paradoxical association of enhanced cholesterol efflux with increased incident cardiovascular risks.

Authors:  Xin-Min Li; Wai Hong Wilson Tang; Marian K Mosior; Ying Huang; Yuping Wu; William Matter; Vivian Gao; David Schmitt; Joseph A Didonato; Edward A Fisher; Jonathan D Smith; Stanley L Hazen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-03-21       Impact factor: 8.311

9.  Novel Pathways of Apolipoprotein A-I Metabolism in High-Density Lipoprotein of Different Sizes in Humans.

Authors:  Carlos O Mendivil; Jeremy Furtado; Allyson M Morton; Liyun Wang; Frank M Sacks
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-11-05       Impact factor: 8.311

10.  Proteomic analysis of HDL from inbred mouse strains implicates APOE associated with HDL in reduced cholesterol efflux capacity via the ABCA1 pathway.

Authors:  Nathalie Pamir; Patrick Hutchins; Graziella Ronsein; Tomas Vaisar; Catherine A Reardon; Godfrey S Getz; Aldons J Lusis; Jay W Heinecke
Journal:  J Lipid Res       Date:  2015-12-15       Impact factor: 5.922
View more
  7 in total

1.  Association of Dimethylguanidino Valeric Acid With Partial Resistance to Metabolic Health Benefits of Regular Exercise.

Authors:  Jeremy M Robbins; Matthew Herzig; Jordan Morningstar; Mark A Sarzynski; Daniel E Cruz; Thomas J Wang; Yan Gao; James G Wilson; Claude Bouchard; Tuomo Rankinen; Robert E Gerszten
Journal:  JAMA Cardiol       Date:  2019-07-01       Impact factor: 14.676

2.  The pattern of apolipoprotein A-I lysine carbamylation reflects its lipidation state and the chemical environment within human atherosclerotic aorta.

Authors:  Shawna Battle; Valentin Gogonea; Belinda Willard; Zeneng Wang; Xiaoming Fu; Ying Huang; Linda M Graham; Scott J Cameron; Joseph A DiDonato; John W Crabb; Stanley L Hazen
Journal:  J Biol Chem       Date:  2022-03-15       Impact factor: 5.486

3.  Engineered biomimetic nanoparticle for dual targeting of the cancer stem-like cell population in sonic hedgehog medulloblastoma.

Authors:  Jinhwan Kim; Abhinav Dey; Anshu Malhotra; Jingbo Liu; Song Ih Ahn; Yoshitaka J Sei; Anna M Kenney; Tobey J MacDonald; YongTae Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-15       Impact factor: 11.205

4.  β3-Adrenoceptor activation upregulates apolipoprotein A-I expression in HepG2 cells, which might further promote cholesterol efflux from macrophage foam cells.

Authors:  Xia-Qing Gao; Yan-Fang Li; Zhi-Li Jiang
Journal:  Drug Des Devel Ther       Date:  2017-03-03       Impact factor: 4.162

5.  Genetic control of the mouse HDL proteome defines HDL traits, function, and heterogeneity.

Authors:  Nathalie Pamir; Calvin Pan; Deanna L Plubell; Patrick M Hutchins; Chongren Tang; Jake Wimberger; Angela Irwin; Thomas Q de Aguiar Vallim; Jay W Heinecke; Aldons J Lusis
Journal:  J Lipid Res       Date:  2019-01-08       Impact factor: 5.922

6.  A Standard Lipid Panel Is Insufficient for the Care of a Patient on a High-Fat, Low-Carbohydrate Ketogenic Diet.

Authors:  Nicholas G Norwitz; Vyvyane Loh
Journal:  Front Med (Lausanne)       Date:  2020-04-15

Review 7.  High-density lipoprotein metabolism and reverse cholesterol transport: strategies for raising HDL cholesterol.

Authors:  Katerina Tosheska Trajkovska; Sonja Topuzovska
Journal:  Anatol J Cardiol       Date:  2017-08       Impact factor: 1.596
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.